Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 8;14(8):2550.
doi: 10.3390/jcm14082550.

Unraveling the Enigma: Food Cobalamin Malabsorption and the Persistent Shadow of Cobalamin Deficiency

Affiliations
Review

Unraveling the Enigma: Food Cobalamin Malabsorption and the Persistent Shadow of Cobalamin Deficiency

Emmanuel Andrès et al. J Clin Med. .

Abstract

Food cobalamin malabsorption (FCM) represents a prevalent, often underdiagnosed, etiology of vitamin B12 deficiency, particularly within an aging population. Unlike pernicious anemia, an autoimmune disorder targeting intrinsic factor, FCM stems from the impaired release of cobalamin from food proteins, primarily due to age-related gastric changes, medication-induced gastric hypochlorhydria, metformin, or non-immune atrophic gastritis. The clinical presentation of FCM mirrors that of general cobalamin deficiency, encompassing a spectrum of neurological (peripheral neuropathy, cognitive decline), hematological (megaloblastic anemia), and gastrointestinal (glossitis, anorexia) manifestations. Given the potential for irreversible neurological sequelae, early detection and intervention are paramount. High-dose oral cobalamin (125-250 mcg daily) has demonstrated efficacy, offering a convenient and cost-effective alternative to parenteral administration.

Keywords: cobalamin deficiency; cobalamin treatment; food cobalamin malabsorption; pernicious anemia; vitamin B12 deficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflicts of interest.

Figures

Figure 1
Figure 1
Pathophysiology of pernicious anemia (Biermer’s disease) and food cobalamin malabsorption [13]. Legend: B: vitamin B12, HCI: hydrochloric acid, I: intrinsic factor, P: animal protein, PPI: proton pump inhibitor, R: protein, TC: transcobalamin.

References

    1. Guéant J.L., Guéant-Rodriguez R.M., Alpers D.H. Chapter Nine—Vitamin B12 absorption and malabsorption. In: Litwack G., editor. Vitamins and Hormones. Volume 119. Academic Press; Cambridge, MA, USA: 2022. [(accessed on 27 March 2025)]. pp. 241–274. Available online: https://www.sciencedirect.com/science/article/pii/S0083672922000164. - PubMed
    1. NICE CKS Anaemia—B12 and Folate Deficiency. 2023. [(accessed on 29 December 2023)]. Available online: https://cks.nice.org.uk/topics/anaemia-b12-folate-deficiency.
    1. Jajoo S.S., Zamwar U.M., Nagrale P. Etiology, Clinical Manifestations, Diagnosis, and Treatment of Cobalamin (Vitamin B12) Deficiency. Cureus. 2024;16:e52153. doi: 10.7759/cureus.52153. - DOI - PMC - PubMed
    1. Carmel R., Sinow R.M., Siegel M.E., Samloff I.M. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch. Intern. Med. 1988;148:1715–1719. - PubMed
    1. Pardo-Cabello A.J., Manzano-Gamero V., Puche-Cañas E. Vitamin B12: For more than just the treatment of megaloblastic anemia? Rev. Clin. Esp. 2023;223:114–119. - PubMed

LinkOut - more resources